#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenocortical carcinoma Marfan's syndrome Fatty acid oxidation disorder Human papilloma virus immunisation Congenital generalised lipodystrophy Cushing's syndrome Krabbe's disease Castleman's disease Mantle cell lymphoma Adenocarcinoma pancreas Follicular lymphoma stage I Hereditary hypophosphataemic rickets Neoplasm X-linked lymphoproliferative syndrome Astrocytoma More trials…

    Learn about Rare Diseases

    Amyotrophic lateral sclerosis – Treatment Wiskott-Aldrich syndrome Synovial sarcoma metastatic – Diagnostics Pulmonary sarcoidosis – Diagnostics Behcet’s syndrome – Basic Information Nodal marginal zone B-cell lymphoma Atypical teratoid/rhabdoid tumour of CNS – Treatment X-linked lymphoproliferative syndrome – Trials in Disease Angiosarcoma – Treatment Aicardi-Goutieres syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Camizestrant Sodium Cromoglicate Nirmatrelvir Diphenhydramine Pembrolizumab SODIUM IBANDRONATE Fluorouracil Sodium Bepirovirsen Potassium Iodide Levosimendan Nitrous Oxide Barzolvolimab Progesterone Pc14586 Delafloxacin Dextrose Bp Sodium Valproate Skb264 Benztropine Mesylate Mirodenafil Dihydrochloride More therapies…

    Learn about Your Condition

    Pulmonary embolism Diarrhoea Cold type haemolytic anaemia Rosai-Dorfman syndrome Acute leukaemia Bladder cancer stage II Anaemia of pregnancy Psychotic behaviour Vomiting Chondrosarcoma metastatic Heparin resistance Low cardiac output syndrome Follicular lymphoma stage III Glomerulonephritis chronic Thrombolysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Satralizumab for Children with Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Satralizumab
    France Italy Poland

  • Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

    Recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    • Interstitial lung disease
    Investigated Drugs:
    • Amlitelimab
    • Bi 1015550
    Austria Belgium Denmark France Germany Italy +5

  • Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Acetate
    • H2-Receptor Antagonists
    • Sacituzumab Tirumotecan
    Austria Czechia France Germany Hungary Ireland +4

  • Study of Fecal Microbiota Transplantation combined with atezolizumab and bevacizumab in patients with unresectable liver cancer who progressed after initial treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Macrogol 3350
    • Sodium Ascorbate
    • Macrogol 4000
    Italy

  • Study on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IIIA
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    Austria Belgium Estonia France Ireland Italy +1

  • Study on the Effects of IMU-838 (Vidofludimus Calcium) for Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    2 1
    Investigated Drugs:
    • Vidofludimus Calcium
    Bulgaria Germany Poland Romania
Previous Page
1 … 649 650 651 652 653 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!